What is ScreenSafe?
ScreenSafe, Inc. operates as a specialized drug testing management organization, providing comprehensive Drug-Free Workplace services designed to mitigate risks associated with substance abuse. By addressing the direct correlation between drug use and increased absenteeism, medical expenditures, and workplace accidents, the firm serves a diverse clientele ranging from pharmaceutical enterprises to specialized construction and plumbing unions. Their deep expertise in navigating complex union policies, including IBEW and various trade locals, establishes ScreenSafe as a critical partner for organizations prioritizing industrial safety and human capital optimization.
How much funding has ScreenSafe raised?
ScreenSafe has raised a total of $113K across 1 funding round:
Debt
$113K
Debt (2021): $113K with participation from PPP
Key Investors in ScreenSafe
PPP
Public-Private Partnership
What's next for ScreenSafe?
Following this late-stage capital injection, ScreenSafe is expected to prioritize the scaling of its digital management infrastructure and the expansion of its service delivery network. The strategic deployment of these funds will likely focus on enhancing the firm's proprietary compliance platforms, allowing for more seamless integration with the evolving regulatory requirements of its industrial and corporate partners. As the company matures, the focus will shift toward deepening its market penetration within the construction and pharmaceutical sectors, leveraging its established reputation for policy expertise to capture a larger share of the enterprise safety management market.
See full ScreenSafe company page
